2LARTH®, a micro-immunotherapy medicine, exerts anti-inflammatory effects in vitro and reduces TNF-α and IL-1β secretion
Ilaria Floris,1 Kurt Appel,2 Thorsten Rose,2 Beatrice Lejeune3 1Clinical Affairs, Labo’Life France, Moutiers-Sous-Chantemerle, France; 2VivaCell Biotechnology GmbH, Denzlingen, Germany; 3Clinical Affairs, Labo’Life Belgium, Gembloux, Belgium Background: Tumor necrosis factor-&...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5028a473e57f43d7bfd20b8c65bd0606 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|